Jason S. Fisherman - Concepedia

Concepedia

Author

Jason S. Fisherman

National Cancer Institute

Also Known As

J Fisherman, J S Fisherman, J. S. Fisherman, JASON FISHERMAN, Jason Fisherman, Jason S. Fisherman

13

Publications

1.9K

Citations

10

H-Index

32

Concepts

All Affiliations

National Cancer Institute National Institutes of Health

JS

About

Jason S. Fisherman is an author at National Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.5K
2	Pathology	2	2	1.3K
3	Public Health	1	1	395
4	Biochemistry	1	1	21
5	Immunology	1	1	920

Jason S. Fisherman

×

9

Publications

1.9K

Citations

9

H-Index

	Year	Citations
Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production Jonathan Pollock, David A. Williams, Mary A. Gifford, Nature Genetics InflammationDisease MechanismGranulocyteImmune Cell DevelopmentPathogenesis	1995	920
Cardiac disturbances during the administration of taxol. Eric K. Rowinsky, William P. McGuire, Thomas Guarnieri, Journal of Clinical Oncology Heart FailureChemoprevention StrategyCardiac DisturbancesCardiovascular PharmacologyPathology	1991	395
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. Edward L. Trimble, Jascha Adams, D. Vena, Journal of Clinical Oncology	1993	272
Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer Bernhard C. Pestalozzi, George A. Sotos, Peter L. Choyke, Cancer	1993	78
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. Jason S. Fisherman, K H Cowan, Marianne Noone, Journal of Clinical Oncology	1996	68
Pharmacokinetics of Taxol and Doxorubicin Administered Alone and in Combination by Continuous 72-Hour Infusion Stacey L. Berg, Kenneth H. Cowan, Frank M. Balis, JNCI Journal of the National Cancer Institute Pediatric BranchPharmacotherapyMetronomic ChemotherapyPhysiologically-based Pharmacokinetic ModelingPre-clinical Pharmacology	1994	62
Clinical development of Taxol. Susan G. Arbuck, Michaele C. Christian, Jason S. Fisherman, PubMed Stable Microtubule BundlesPhase Ii EvaluationOncologyMedicineClinical Development	1993	59
Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer. Joyce O’Shaughnessy, Jason S. Fisherman, K H Cowan PubMed	1994	30
Action of sulfhydryl reagents on cholinergic mechanisms in synaptosomes Akemichi Baba, Jason S. Fisherman, Jack R. Cooper Biochemical Pharmacology BiochemistryMedicineNeurotransmitterCholinergic MechanismsNeurotransmission	1979	21

Page 1